KURE Pain Management Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • KURE Pain Management's estimated annual revenue is currently $4.2M per year.(i)
  • KURE Pain Management's estimated revenue per employee is $189,000

Employee Data

  • KURE Pain Management has 22 Employees.(i)
  • KURE Pain Management grew their employee count by -15% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M369%N/AN/A
#2
$160.7M47610%N/AN/A
#3
$8.6M4011%N/AN/A
#4
$17.3M7111%N/AN/A
#5
$28.4M1057%N/AN/A
#6
$10.2M479%N/AN/A
#7
$6.7M313%N/AN/A
#8
$34.3M127-8%N/AN/A
#9
$7.1M33-3%N/AN/A
#10
$6.7M313%N/AN/A
Add Company

What Is KURE Pain Management?

KURE Pain Management has assembled the top specialists in the region to offer the most advanced, minimally invasive treatments for neck pain and back pain. All of our pain management physicians are board certified in pain management. KURE Pain Management's procedures are a safe and effective alternative to open back or neck surgery. Our multi-disciplinary approach delivers targeted pain relief…fast results. We have extensive experience treating patients with a wide range of pain including chronic neck pain, back pain, shoulder pain and arthritis pain, as well as treatment for a number of conditions including carpel tunnel syndrome, rotator cuff tears, ACL injuries to name a few. We have many locations to serve you: Annapolis, Chestertown, Easton, Glen Burnie, Kent Island, Leonardtown and Waldorf, Maryland as well as a Physical Therapy office in Annapolis.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$4.2M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

KURE Pain Management News

2022-04-06 - Signaling pathways of gastrointestinal stromal tumors | IJGM

Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor. ... Wada R, Arai H, Kure S, et al.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M2216%N/A
#2
$2.6M23-21%N/A
#3
$4.7M23-12%N/A
#4
$3.7M230%N/A
#5
$2.3M23N/AN/A